You have 9 free searches left this month | for more free features.

Pterygium

Showing 51 - 75 of 198

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in Richmond (10 GY in 5 daily fractions, 20 GY in 10 daily fractions)

Terminated
  • Alzheimer's Disease
  • 10 GY in 5 daily fractions
  • 20 GY in 10 daily fractions
  • Richmond, Virginia
    Virginia Commonwealth University
Nov 18, 2021

Cataract, Postoperative Complications, Artificial Intelligence Trial in Guangzhou (An artificial intelligence system for

Unknown status
  • Cataract
  • +2 more
  • An artificial intelligence system for postoperative management of cataract patients
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Dec 1, 2019

Ophthalmology Intelligent Diagnostic System

Completed
  • Ophthalmopathy
  • Artificial Intelligence
  • Ophthalmology diagnostic system.
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Oct 17, 2019

Pterygium Trial in Jinan (Tissue engineering conjunctiva transplantation)

Unknown status
  • Pterygium
  • Tissue engineering conjunctiva transplantation
  • Jinan, Shandong, China
    Shandong Eye Hospital
Aug 12, 2017

Conjunctival Autograft Trial in Ramat Gan (Fibrin Glue, Quixil, Suture)

Completed
  • Conjunctival Autograft
  • Fibrin Glue, Quixil
  • Suture
  • Ramat Gan, Israel
    Sheba_Medical_Center
Aug 7, 2017

Low-temperature Plasma Surgery System in Pterygium With Fibrin

Completed
  • Pterygium
  • Low-temperature Plasma Surgery System
  • (no location specified)
Jun 26, 2017

Pterygium Trial in Miami (ranibizumab)

Completed
  • Pterygium
  • Miami, Florida
    Bascom Palmer Eye Institute
Jul 7, 2017

Peripheral Artery Disease, Atherosclerosis, Artery Diseases, Peripheral Trial in Worldwide (device, drug, procedure)

Active, not recruiting
  • Peripheral Artery Disease
  • +4 more
  • RANGERâ„¢ Paclitaxel Coated Balloon
  • +2 more
  • Fairhope, Alabama
  • +66 more
Jan 24, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (UT-15C (treprostinil diolamine))

Completed
  • Pulmonary Arterial Hypertension
  • UT-15C (treprostinil diolamine)
  • Phoenix, Arizona
  • +152 more
May 6, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham: Applicator Without Needle, Active

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Dothan, Alabama
  • +112 more
Jul 6, 2021

Diabetes, Type 2 Trial in China (, linagliptin, background therapy)

Completed
  • Diabetes Mellitus, Type 2
  • placebo
  • +2 more
  • Beijing, China
  • +24 more
Mar 24, 2020

Neovascular Age-Related Macular Degeneration Trial in United States (PDS Implant filled with 100 mg/mL Ranibizumab, Intravitreal

Completed
  • Neovascular Age-Related Macular Degeneration
  • PDS Implant filled with 100 mg/mL Ranibizumab
  • Intravitreal Injections of 10 mg/mL Ranibizumab
  • Mesa, Arizona
  • +76 more
Feb 28, 2022

Surgery, Sedation Trial in Boston (Triazolam, Midazolam, Microcrystalline Cellulose)

Completed
  • Surgery
  • Sedation
  • Boston, Massachusetts
    Boston Medical Center
Aug 7, 2020

Chronic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

Completed
  • Chronic Kidney Disease
  • Finerenone (BAY94-8862)
  • Placebo
  • Birmingham, Alabama
  • +977 more
Jun 29, 2021

Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan

Completed
  • Glaucoma
  • Ocular Hypertension
  • no intervention
  • (no location specified)
Feb 1, 2021

Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)

Completed
  • Prostate Cancer
  • Boston, Massachusetts
  • +91 more
Jan 18, 2023

Clostridium Difficile Infection Trial in Worldwide (C. difficile Toxoid Vaccine, Placebo: 0.9% normal saline)

Terminated
  • Clostridium Difficile Infection
  • C. difficile Toxoid Vaccine
  • Placebo: 0.9% normal saline
  • Huntsville, Alabama
  • +334 more
Mar 21, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +102 more
Jan 14, 2021

Prevention & Control Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Aspirin )

Completed
  • Prevention & Control
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +5 more
  • Birmingham, Alabama
  • +564 more
Nov 3, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Avelumab, Chemoradiation)

Terminated
  • Squamous Cell Carcinoma of the Head and Neck
  • Fayetteville, Arkansas
  • +315 more
Sep 20, 2021

HIV Trial in Worldwide (VRC01, Placebo for VRC01)

Completed
  • HIV Infections
  • VRC01
  • Placebo for VRC01
  • Gaborone, South-East District, Botswana
  • +20 more
Feb 8, 2022

Non-Small-Cell Lung Carcinoma NSCLC Trial in Worldwide (MEDI4736 (Durvalumab), MEDI4736 (Durvalumab)+Tremelimumab, Paclitaxel +

Active, not recruiting
  • Non-Small-Cell Lung Carcinoma NSCLC
  • MEDI4736 (Durvalumab)
  • +7 more
  • Scottsdale, Arizona
  • +198 more
Jul 12, 2022

Dyslipidemia Trial in Worldwide (Evolocumab, Placebo)

Completed
  • Dyslipidemia
  • Evolocumab
  • Placebo
  • Birmingham, Alabama
  • +1286 more
Jul 15, 2022

Atherosclerosis Trial in China (Rosuvastatin, Placebo)

Completed
  • Atherosclerosis
  • Beijing, China
  • +23 more
Nov 25, 2019

Geographic Atrophy, Age-related Macular Degeneration Trial in United States (LFG316, Sham, LFG316 Lower dose)

Completed
  • Geographic Atrophy
  • Age-related Macular Degeneration
  • Phoenix, Arizona
  • +18 more
Dec 9, 2020